Open AccessCOST ANALYSIS OF DISEASE MODIFYING ANTI RHEUMATIC DRUGS: THE INDIAN SCENARIO
Author(s) -
Zarrin Ansari,
Sharmada Nerlekar,
Sagar Karia,
Sudhir Pawar
Publication year - 2020
Publication title -
global journal for research analysis
Language(s) - English
DOI - 10.36106/gjra/6704605
Subject(s) - rheumatoid arthritis , medicine , methotrexate , disease , socioeconomic status , indirect costs , physical therapy , biological drugs , environmental health , business , population , accounting